Drug Shortage Report for TOBREX

Last updated on 2017-09-14 History
Report ID 20963
Drug Identification Number 00513962
Brand name TOBREX
Common or Proper name TOBREX 0.3% SOLN 5ML
Company Name NOVARTIS PHARMACEUTICALS CANADA INC
Market Status MARKETED
Active Ingredient(s) TOBRAMYCIN
Strength(s) .3%
Dosage form(s) SOLUTION
Route of administration OPHTHALMIC
Packaging size 5 ml
ATC code S01AA
ATC description ANTIINFECTIVES
Reason for shortage Demand increase for the drug.
Anticipated start date
Actual start date 2017-07-20
Estimated end date 2017-09-12
Actual end date 2017-09-13
Shortage status Resolved
Updated date 2017-09-14
Company comments
Health Canada comments
Contact Address 385 BOUCHARD BLVD
DORVAL, QUEBEC
CANADA H9S 1A9
Company contact information customer.relations@novartis.com

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v6 2017-09-14 English Compare
v5 2017-09-13 French Compare
v4 2017-09-13 English Compare
v3 2017-09-05 French Compare
v2 2017-09-05 French Compare
v1 2017-09-05 English Compare